PRINT ALL
Dr. Douville is an entrepreneurial executive with a track record of success in starting up biotech companies. Dr. Douville co-founded Genizon Biosciences (formerly Galileo Genomics) a population genetics company. As founding CEO, he negotiated Genizon’s seminal strategic alliance with Myriad Genetics and subsequently, as Chief Business Officer, he played a key role in preparing the company for its Series A financing. After leaving Genizon, Dr. Douville was involved in the start-up of Allostera Pharma. He has since been involved in conceptualizing and promoting Milestone Pharmaceuticals leading to its first round of financing in 2006. Dr. Douville obtained his Ph.D. in neurosciences from McGill University in 1991 and subsequently pursued research activities at the University of Zurich, Switzerland.